Europe Blood and Blood Components Market – Development Status and Opportunities Forecast to 2024

The blood components segment of had dominated the Europe blood and blood components market share in 2017 and is estimated to grow to $3.9 billion by 2024. Increasing rates of conditions like bleeding disorders, anemia along with procedures like aesthetic surgeries, infections and chemotherapy will contribute towards the Europe blood and blood components industry size considerably. Blood components that are of higher costs and have a specific use are expected to impact positively on the revenue size over the forecast time period.

Rising number of trauma cases, surgical procedures and road accidents will fuel Europe blood and blood components market size owing to increased need for blood transfusions to address loss of blood from the injuries.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3398

Growing trend of unhealthy lifestyle, rising pollution and eating habits play the role of a catalyst in escalating the risk of cancer, which may influence the industry growth in Europe. With the prevalence of cancer and its various forms, cancer treatment application segment is expected to progress at a faster pace. To compensate for low blood cell count, blood components that comprises of plasma, red blood cells, white blood cells and platelets are vastly used.

Blood transfusion is a medical procedure of transferring blood or blood products into patient’s body through veins. Rising number of trauma cases, road accidents, cosmetic surgeries and surgical procedures in chronic diseases that require blood transfusion owing to large amount of blood loss has influenced the demand for these products across hospitals. According to a new research report, Europe blood and blood components market is expected to surpass an annual valuation of US$5 billion by 2024.

The trauma and surgery application segment had held more than 40% of Europe blood and blood components market share in 2017. Surge in the number of injuries that lead to a surgery will boost the demand for blood and blood components in the forthcoming years. Most trauma cases need massive amounts of blood transfusion.

Russia blood and blood components market is expected to experience a considerable rate of growth over the projected time period. Surge in the number of blood donations will play a major role in boosting the industry growth.

With the surge in the number of covid-19 positive cases in Europe, this pandemic has hampered blood and blood components delivery and demand in many ways such as reduced number of patients, surgeries, demand for blood, medical supplies and rising concerns of being infected with this deadly virus. However, in a breakthrough to fight against coronavirus, a blood component plasma is being widely used in plasma therapy to cure infected patients.

Notable associations like NHS Blood and Transplant (NHSBT), Northern Island Blood Transfusion Service, IFRC and Welsh Blood Services operate in Europe. The associations have been introducing and implementing strategic initiatives that include awareness initiatives, expansion strategies, and collaborations that have been enhancing the market awareness regarding various products available and proliferating Europe blood and blood components market trends.

Request for customization @ https://www.decresearch.com/roc/3398

Partial Chapter of the Table of Content

Chapter 4. Europe Blood and Blood Components Market, By Product

4.1. Key segment trends

4.2. Whole blood

4.2.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3. Blood components

4.3.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3.1.2.Market size, by country, 2013 – 2024 (Units)

4.3.2. Red blood cells

4.3.2.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.2.2.Market size, by country, 2013 – 2024 (Units)

4.3.3. Platelets

4.3.3.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.3.2.Market size, by country, 2013 – 2024 (Units)

4.3.4. Plasma

4.3.4.1. Europe blood and blood components market size, by country, 2013 – 2024 (USD Million)

4.3.4.2.Market size, by country, 2013 – 2024 (Units)

4.3.5. White blood cells

4.3.5.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.5.2.Market size, by country, 2013 – 2024 (Units)

Chapter 5. Europe Blood and Blood Components Market, By Application

5.1. Key segment trends

5.2. Anemia

5.2.1.Market size, by country, 2013 – 2024 (USD Million)

5.3. Trauma & surgery

5.3.1.Market size, by country, 2013 – 2024 (USD Million)

5.4. Cancer treatment

5.4.1.Market size, by country, 2013 – 2024 (USD Million)

5.5. Bleeding disorders

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/europe-blood-and-blood-components-market